In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Mobocertinib is an oral targeted therapy primarily used for the treatment of loc···【more】
Release date:2026-02-26Recommended:210
Mobocertinib is a targeted therapy drug for non-small cell lung cancer (NSCLC) w···【more】
Release date:2026-02-26Recommended:255
The current price of Mobocertinib after medical insurance reimbursement in China···【more】
Release date:2026-02-26Recommended:227
The current price of Mobocertinib is influenced by purchasing channels, regional···【more】
Release date:2026-02-26Recommended:242
The usual recommended dose of sotorasib is 960 mg (8 tablets x 120 mg) once dail···【more】
Release date:2026-02-25Recommended:221
Sotorasib is a targeted therapy for KRAS G12C-mutated non-small cell lung cancer···【more】
Release date:2026-02-25Recommended:311
Lumykras (generic name: Sotorasib) is a prescription targeted therapy drug for n···【more】
Release date:2026-02-25Recommended:255
The price of Sotorasib varies significantly depending on the region, purchasing ···【more】
Release date:2026-02-25Recommended:223
The side effects of Avatrombopag are generally manageable, with most being mild ···【more】
Release date:2026-02-24Recommended:225
Avatrombopag is an oral medication used to treat thrombocytopenia (low platelet ···【more】
Release date:2026-02-24Recommended:216
The price of Avatrombopag varies significantly, typically ranging from a few hun···【more】
Release date:2026-02-24Recommended:252
Lucius Pharmaceuticals Avatrombopag is a prescription medication used to treat t···【more】
Release date:2026-02-24Recommended:269